GSK shares fall following $10.6 bln Nuvalent acquisition deal
Investing.com Gold reports: GSK shares fall following $10.6 bln Nuvalent acquisition deal. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: GSK shares fall following $10.6 bln Nuvalent acquisition deal. Full body text was unavailable at ingest time, so this brief is based on headline context.